Kennedy lets pharmacies make six unapproved peptides despite FDA scientist objections
Health Secretary Robert F. Kennedy Jr. announced that the Department of Health and Human Services will allow small compounding pharmacies to make six peptides. The Food and Drug Administration has not approved the six. Peptides are short chains of amino acids, and several of them are promoted by online influencers. The permission is temporary and bypasses the usual approval route. The secretary declared it unilaterally. FDA scientists opposed the move, according to people familiar with the internal process. The department has not said how long the permission lasts.
Compounded drugs skip the safety and effectiveness testing required for approved drugs. By using a temporary permission, the department makes the products legal to sell without that testing. If side effects appear, there is little data to guide doctors.
If you see peptide injections offered online or at a local pharmacy, a legal product is not the same as a tested one. Ask your doctor and check what is in the vial.
Supporters, including Kennedy, argue that people already buy peptides in gray markets and that access through licensed pharmacies is safer and gives patients choices.
FDA scientists and drug-safety experts say the six compounds lack solid evidence for safety or benefit. They fear the shortcut erodes the approval standards that protect patients.
Confirmed: the permission for six peptides and the FDA scientists' objections. Not confirmed: the exact list and the end date. Watch for the pharmacy guidance and any pushback from lawmakers.
DailyDrop U.S. No. 25 · October 29, 2026